PennyPerformers.com: "Penny Stocks that Perform" picks are: CIEN, LIFE, MMTC, VRSN

"Penny Stocks that Perform" picks are: Ciena(R) Corporation (NASDAQ: CIEN), Life Technologies Corporation (NASDAQ: LIFE), Micro Imaging Technology, Inc. (OTCBB: MMTC), VeriSign, Inc. (NASDAQ: VRSN)

Sign-up for our FREE Stock Alerts AND NEWSLETTER at www.pennyperformers.com

Jun 29, 2009 -- Ciena(R) Corporation (NASDAQ: CIEN), the network specialist, today announced that Lifeline Data Centers, an Indianapolis-based provider of strategic data center outsourcing facilities and services, has deployed the CN 4200(R) FlexSelect(R) Advanced Services Platform to provide high-performance, low-latency connectivity over dark fiber between its existing data center in downtown Indianapolis and its new 460,000-square foot state-of-the-art data center facility twelve miles outside of the city.

Serving healthcare, retail, government, biotech and other industries, Lifeline Data Centers provides customers with cost-effective data center space and outsourcing, as well as managed IT services and access to more than 20 service providers. As part of a project to dramatically expand its capacity, Lifeline is transforming the former Eastgate Mall - one of Indianapolis' first retail shopping centers - into a data center, which currently includes 65,000 square feet of space and will ultimately house 460,000 square feet spread across five buildings on the property.

After reviewing various options for connecting the two sites, Lifeline secured dark fiber and deployed Ciena's CN 4200 at each data center to meet its connectivity requirements. Key selection criteria included the platform's flexible support of multiple services, carrier-class reliability and the ability to grow capacity in increments, which enables Lifeline to buy and deploy only the capacity it requires when it needs it without sacrificing system capacity. In the cost-competitive data center market, this is crucial as it directly aligns Lifeline's transport costs with secured business versus investing in capacity based purely on market speculation or uncertain future demand.

"The ability to offer our clients a network optimized for speed and reliability is critical to both our business and theirs," said Rich Banta, founder and CTO at Lifeline Data Centers. "Ciena's CN 4200 provides a carrier-class network foundation that allows us to control costs while delivering advanced connectivity services to our customers that complement our state-of-the-art data center facilities and managed services."

Lifeline is using the new data center connection to transport customer traffic between sites, backhaul traffic from the new site to connect to service providers in their original data center, and to directly sell its own bandwidth.

"Across nearly all industries - from algorithmic financial trading to software-as-a-service applications or electronic medical records - information, entertainment and applications are being aggregated, stored and delivered from increasingly sophisticated data centers. The success of that model requires a combination of hardware, software, services and network connectivity optimized for performance, reliability and security," said Steve Alexander, chief technology officer at Ciena. "Lifeline is another example of how data center operators can leverage the flexibility, performance and modular capacity of the CN 4200 to create nimble, service-driven data center connections for cost-effectively transporting any mix of traffic over any distance."

About Ciena

Ciena specializes in practical network transition. We offer leading network infrastructure solutions, intelligent software and a comprehensive services practice to help our customers use their networks to fundamentally change the way they compete. With a global presence, Ciena leverages its heritage of practical innovation to deliver maximum performance and economic value in communications networks worldwide. We routinely post recent news, financial results and other important announcements and information about Ciena on our website.

About Lifeline Data Centers

Lifeline Data Centers, LLC is an Indianapolis-based company that provides computer room facilities for public, private and government clients. Lifeline provides the highest quality hardened facilities with multiple telecommunications providers and flexible options. Clients use Lifeline to protect their primary and backup computer systems, and to avoid the costs of building their own computer room facilities. Lifeline also provides managed services including remote backup, regular maintenance and emergency services.

Jun 29, 2009 -- Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), today announced the commercial availability of a state-of-the-art, automated, research-use microarray system designed to simplify immunogenetic testing, including human leukocyte antigen (HLA) research. The new Prodigy(TM) system is an advanced DNA and protein analysis tool that simplifies and accelerates histocompatibility research, vaccine and drug development, and disease association studies.

The Prodigy system is the first high-throughput, next-generation, sequence-specific oligonucleotide probe system that streamlines sample workflow for hybridizing, detecting and analyzing HLA markers in large-volume variation analysis and genotyping research studies. HLA markers are cell-surface proteins that play a key regulation role in the human immune system, functioning as an alert mechanism when the body has been invaded by foreign proteins or molecules, such as bacteria, parasites and viruses. The Prodigy system represents a significant advancement in technologies for this type of research, providing scientists with a simplified workflow for cleaner, consistent and reproducible results, while reducing hands-on interaction with the system, resulting in decreased variability, errors and the need for repeat testing.

The Prodigy system features several technological advancements over other systems in the market. It has 5-times the density capacity of current bead-based assays and is enabled by push-button, walk-away automation, enabling researchers to spend valuable time reviewing data or preparing more samples. Prodigy is inherently scalable to include multiplexing capability for more than 500 analytes, while providing high resolution and unmatched efficiency and reliability.

It is also capable of industry-leading throughput that equates to approximately 290 genotypes in 9 hours, and includes integrated software that simplifies data analysis and interpretation. And, with capacity for more than 500 analytes, the Prodigy system is uniquely scalable to accommodate new alleles to be identified in the future, enabling it to be easily incorporated into existing infrastructure. This provides researchers with a future-proof technology that will enable them to not only expand, but to also advance their research over a significant period of time.

Jim Janicki, VP & General Manager of Life Technologies' Transplantation Diagnostics Business

"The development of the Prodigy microarray system is the latest development in Invitrogen's strategy to make its best-in-class genomic and proteomic technologies available within the HLA research field. This powerful system provides an end-to-end solution that will help researchers advance their immunogenetic studies."

Resources

-- Prodigy System

-- Prodigy System Brochure

About Life Technologies

Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.

Jun 29, 2009 -- Micro Imaging Technology, Inc. (OTCBB: MMTC) announced that it has entered into a strategic business development relationship with OPH Ltd. Hong Kong who will be instrumental in securing a manufacturing partner for the Company in Asia. In addition, OPH will develop this market for the MIT 1000 Rapid Microbial Identification System through its distribution channels by working closely with existing Micro Imaging Technology (MIT) distributors and jointly with MIT to identify and select other strategic partners to expand the Company's MIT 1000 business in Asia.

"The MIT 1000 technology is truly a revolutionary development in rapid detection of microbial pathogens," said David Harris, chairman of OPH Ltd. Mr. Harris further stated, "We are very pleased and excited to partner with MIT in delivering these exceptional technological benefits to Asian producers and consumers. The speed, accuracy and cost-savings provided by the MIT 1000 System will improve the operational efficiencies and bottom line for food and pharmaceutical manufacturers and, most importantly, will contribute to the advancement of the overall safety of their global supply chains."

MIT recently received Performance Test Method (PTM) Certification for the Identification of Listeria from the AOAC Research Institute (RI) and is now focused on accelerating the commercialization of the MIT 1000. "OPH has helped numerous companies quickly and successfully expand their businesses to Asia. Given our objectives of establishing a global presence and lowering product cost, we see the partnership with OPH as a significant first step in our international growth goals," stated Michael Brennan, MIT's Chairman and CEO.

Recent market research information showed that over $4.5 Billion was spent in 2008 for rapid identification in the industrial microbiology market according to Strategic Consulting Inc. (SCI), and is expected to reach $6.2 Billion by 2013. SCI has provided food processing, beverage, pharmaceutical, personal care and other industries with market metrics for over 20 years.

About OPH Ltd.:

OPH is the parent company to GMC Group Limited management consulting firm, GlobalFinancialWire.com corporate communications service, and UltraFuture public relations service. GMC Group will be taking the lead in coordinating and implementing the strategic planning and business development program. Since 1999, OPH and its affiliates have helped manufacturing and technology companies expand their business in Asia and secure equity funding for expansion. OPH estimates that they have helped companies raise over $15 Million (US) and expand businesses by over $100 Million (US) in that period.

About Micro Imaging Technology:

MIT is a California-based public company that has developed and patented a rapid microbial ID System that can revolutionize the pathogenic ID process and annually save thousands of lives and tens of millions of dollars. The System IDs bacteria in minutes, not days, and at a significant per test cost savings when compared to any conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process is totally GREEN requiring only clean water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion and are expanding at an average rate of 10.2 percent annually since 2003.

The System is laser based and uses the proven principles of light scattering in conjunction with proprietary PC-based software algorithms to ID microbes and create a proprietary database. MIT, through independent testing, has proven the ability with high accuracy to ID the most dangerous and pervasive pathogens; E. coli, Listeria, Salmonella, and Staphylococcus aureus (a.k.a. Staph) and twenty (20) other species of bacterium.

The MIT 1000 System has numerous ID applications including food quality control, clinical diagnostics, pharmaceutical quality assurance, semiconductor processing control and water quality monitoring. MIT has chosen to focus initial efforts on food quality control as recent events have created an urgent demand for quicker and cheaper testing -- demands that will promote a high-value return on any investment in MIT's technology.

Jun 29, 2009 -- VeriSign, Inc. (NASDAQ: VRSN), the trusted provider of Internet infrastructure services for the networked world, and Qualys, Inc., the leading provider of on demand IT security risk and compliance management solutions, today announced a strategic relationship whereby iDefense intelligence is integrated with scanning data from QualysGuard(R) Vulnerability Management (VM). The integration drives immediate availability of two new services that combine advanced, in-depth security threat intelligence and vulnerability scanning data, which enables enterprises to protect critical IT assets from compromise or attack, particularly against zero-day threats and vulnerabilities. Zero-day threats are exploitable security vulnerabilities in software that are discovered before the software vendor identified them and begun a process for patching.

Through the first of these services, iDefense has made its iDefense Exclusives security vulnerability data available through QualysGuard(R) VM. Availability of iDefense Exclusives enables Qualys to create scan signatures for zero-day vulnerabilities. This enhancement to QualysGuard VM offers security teams more efficient and accurate risk mitigation capability against zero-day threats and vulnerabilities.

Additionally, the iDefense security intelligence data is integrated with QualysGuard(R) VM to enable customers with the ability to correlate iDefense vulnerability reports with Qualys scan data against IT assets to prioritize vulnerabilities based on severity, business criticality and relevance to the organization. This integration capability, available on the iDefense portal, helps security teams prioritize patch deployments and remediation efforts particularly between full vulnerability scan cycles of their environments.

"As security threats and vulnerabilities continue to evolve, organizations are increasingly looking for tools and solutions that will enable them to proactively prioritize and respond to security attacks in a cost-effective way," said Irida Xheneti, Security Services Research Analyst at IDC. "Through the integration of the VeriSign iDefense security intelligence with the QualysGuard Vulnerability Management solution, organizations will be able to leverage deep security analysis of their respective environment, security intelligence of current threats and vulnerabilities combined with the ability to prioritize actions to vulnerabilities based on asset criticality."

QualysGuard(R) VM is a leading vulnerability management solution that automates the lifecycle of network auditing and vulnerability management across the enterprise, including network discovery and mapping, asset prioritization, vulnerability assessment reporting and remediation tracking according to business risk. QualysGuard(R) VM dramatically reduces security managers' time researching, scanning and fixing network exposures and enables companies to eliminate network vulnerabilities before they can be exploited. The inclusion of public and exclusive vulnerabilities from the iDefense Intelligence team will supplement existing vulnerability data from the Qualys KnowledgeBase to create a powerful threat and vulnerability management capability for our customers worldwide.

"The addition of the deep and analytical research from iDefense as a source of vulnerability data to QualysGuard VM will ensure our clients have the most complete view of threats that pose the greatest risk to the enterprise," said Philippe Courtot, Chairman and CEO, Qualys Inc. "We are pleased to be among the first security solution providers to incorporate this critical intelligence into our solutions."

Leveraged by an extensive, worldwide intelligence gathering network, proven methodology and highly skilled security professionals, VeriSign(R) iDefense(R) Security Intelligence Services deliver deep analysis and actionable intelligence related to vulnerabilities, malicious code and geopolitical threats to protect critical infrastructure from attacks.

"The rapid pace with which modern cyber threats evolve means enterprises need the ability to constantly monitor their points of exposure," said Mike Denning, vice president of Enterprise Security at VeriSign. "It's not practical to run continuous scanning over an entire enterprise IT environment, so the ability for our customers to regularly monitor the threat landscape relative to their latest scan dramatically improves their ability to proactively respond as threats grow in severity."

About VeriSign

VeriSign, Inc. is the trusted provider of Internet infrastructure services for the networked world. Billions of times each day, VeriSign helps companies and consumers all over the world engage in communications and commerce with confidence.

About Qualys

Qualys, Inc. is the leading provider of on demand IT security risk and compliance management solutions -- delivered as a service. Qualys' Software-as-a-Service solutions are deployed in a matter of hours anywhere in the world, providing customers an immediate and continuous view of their security and compliance postures.

The QualysGuard(R) service is used today by more than 3,500 organizations in 85 countries, including 40 of the Fortune Global 100 and performs more than 200 million IP audits per year. Qualys has the largest vulnerability management deployment in the world at a Fortune Global 50 company.

Qualys has established strategic agreements with leading managed service providers and consulting organizations including BT, Etisalat, Fujitsu, IBM, I(TS)2, LAC, SecureWorks, Symantec, Tata Communications, TELUS and VeriSign.

About PennyPerformers.com

PennyPerformers.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

Penny Performers email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Penny Performers Report home page at www.PennyPerformers.com and select the "join now" button.

Join us at www.PennyPerformers.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. PennyPerformers.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyPerformers.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. PennyPerformers.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), PennyPerformers.com is owned and operated by PennyPerformers.com. Neither PennyPerformers.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since PennyPerformers.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in PennyPerformers.com statements and opinions and such statements and opinions cannot be considered independent. PennyPerformers.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. PennyPerformers.com services are often paid for using free-trading shares. PennyPerformers.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: www.PennyPerformers.com/disclaimer.htm

For More Information Regarding Penny Performers, Contact Jason A. Hilton: Rochester, Ny 14609 Office: (866)704-0122 Email: Jason@Newmediaadvisorsllc.com

CONTACT: Jason A. Hilton, New Media Advisors LLC Tel: +1 866 704 0122 e-mail: Jason@Newmediaadvisorsllc.com PennyPerformers.com e-mail: info@pennyperformers.com WWW: http://www.PennyPerformers.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: accounting, agricultural, art, asia, bandwidth, biotechnology, broker, business, california, carrier, ceo, clinical, commerce, communications, computer, consulting, corporate, dealer, disease, dna, email, e-mail, emergency, environment, equity, expansion, exploration, financial results, food, foundation, gasoline, government, hardware, healthcare, hong kong, internet, investment, investment opinion, licenses, manufacturing, market, medicine, nasdaq, new york, online, pharmaceuticals, president, prices, property, public relations, quality control, research, retail, rhode island, sales, science, securities, security, semiconductors, software, species, subscription, technology, telecommunications, traffic, vaccine, water, web, workflow